Sale of 4,126 shares at $57.88 per share.
Reporting Person Urist Marshall · Officer Title EVP, Research & Investments · Transaction Code S
Traded Sep 28, 2026 · Disclosed Sep 30, 2026
Source: SEC Form 4 · 0001838139-26-000026 · filed 2026-09-30 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Royalty Pharma plc (RPRX)." Disclosed 2026-09-30. https://desqlong.com/cards/0001838139-26-000026-1 (retrieved 2026-10-01).